GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Cumberland Pharmaceuticals
Cumberland is a pharmaceutical company specializing in the acquisition and commercialization of niche hospital drugs. Its stock price reflects its ability to identify undervalued assets and successfully sell them, which requires a high degree of expertise.
Share prices of companies in the market segment - Pharma other
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires, develops, and markets niche prescription drugs. We classify it as "Other Pharma." The chart below shows how the market values companies with a diversified drug portfolio.
Broad Market Index - GURU.Markets
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires, develops, and markets niche prescription drugs. It is a component of the GURU.Markets index. The chart below represents the market. See how this company's stock compares to the pharmaceutical sector.
Change in the price of a company, segment, and market as a whole per day
CPIX - Daily change in the company's share price Cumberland Pharmaceuticals
Cumberland Pharmaceuticals' daily share price fluctuations reflect the volatility of the pharmaceutical sector. This metric measures the company's sensitivity to sales of its hospital drugs and the success of its new product acquisitions.
Daily change in the price of a set of shares in a market segment - Pharma other
Cumberland Pharmaceuticals Inc. is a pharmaceutical company. This chart highlights the sector's high volatility. Comparing it to CPIX, which focuses on hospital drugs, helps assess its unique risk profile in this niche.
Daily change in the price of a broad market stock, index - GURU.Markets
Cumberland Pharmaceuticals is a pharmaceutical company specializing in hospital drugs. Its stock price is driven by sales volumes, competition, and development progress. These factors create fluctuations that contribute to the overall volatility of the healthcare sector.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Cumberland Pharmaceuticals
Cumberland Pharmaceuticals' year-over-year performance tells the story of its performance in the niche hospital drug market. Its market cap change over the past 12 months reflects its success in selling its approved drug portfolio, as well as its strategy for acquiring and commercializing new products to serve this specific market niche.
Annual dynamics of market capitalization of the market segment - Pharma other
Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company that acquires and commercializes niche drugs. This chart illustrates how its unique strategy, focus on hospital-market products, and ability to secure favorable deals influence its growth.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Cumberland is a biopharmaceutical company whose stock performance is driven by the success of its drug sales and progress in research. The company's business is not dependent on economic cycles. The chart reflects biotech events rather than macroeconomic data, making it a non-cyclical growth story.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Cumberland Pharmaceuticals
Cumberland Pharmaceuticals is a pharmaceutical company specializing in hospital medications. Its monthly performance reflects sales of its product portfolio and its acquisitions. Quarterly revenue and profitability reports are key to its valuation.
Monthly dynamics of market capitalization of the market segment - Pharma other
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires and develops niche prescription drugs for hospital and outpatient use. The chart below shows the overall dynamics of the pharmaceutical sector, where Cumberland occupies its niche.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Cumberland Pharmaceuticals is a pharmaceutical company specializing in niche drugs. Its performance depends on sales of its existing portfolio and successful acquisitions of new products. This makes it less volatile than biotech startups, but still susceptible to industry-specific events.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Cumberland Pharmaceuticals
Cumberland, a small pharmaceutical company, depends on sales of its niche drug portfolio for its weekly performance. News about generic competition or, conversely, the acquisition of rights to a new product can cause short-term fluctuations.
Weekly dynamics of market capitalization of the market segment - Pharma other
Cumberland Pharmaceuticals and the entire small pharmaceutical sector are responding to common challenges, such as generic competition and pricing pressure. The chart shows how a company with a diversified portfolio fares against this backdrop.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Cumberland Pharmaceuticals and the entire small pharmaceutical sector are responding to common challenges, such as generic competition and pricing pressure. The chart shows how a company with a diversified portfolio fares against this backdrop.
Market capitalization of the company, segment and market as a whole
CPIX - Market capitalization of the company Cumberland Pharmaceuticals
Cumberland Pharma's market capitalization is the financial valuation of a specialty pharmaceutical company that acquires and commercializes niche hospital drugs. The chart reflects its conservative business model. Its dynamics tell a story about how investors assess its ability to discover new products and generate stable cash flow.
CPIX - Share of the company's market capitalization Cumberland Pharmaceuticals within the market segment - Pharma other
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires, develops, and markets prescription drugs, primarily for the hospital segment. Its market share reflects its niche business model. The chart below shows its market share in the hospital drug market.
Market capitalization of the market segment - Pharma other
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires and develops niche drugs. The chart below shows the overall market capitalization of this entire sector. In this area, Cumberland avoids the risks of early development by focusing on already approved but undervalued products.
Market capitalization of all companies included in a broad market index - GURU.Markets
The pharmaceutical companies visible in the chart often focus on niche products. Cumberland Pharmaceuticals sells a portfolio of specialized hospital drugs. Its market capitalization is a measure of its ability to acquire and commercialize such niche products.
Book value capitalization of the company, segment and market as a whole
CPIX - Book value capitalization of the company Cumberland Pharmaceuticals
Cumberland's book value is its portfolio of niche pharmaceuticals. The chart reflects the value of its manufacturing contracts and inventory of approved drugs for hospital and specialty use. These are tangible assets that generate stable revenue.
CPIX - Share of the company's book capitalization Cumberland Pharmaceuticals within the market segment - Pharma other
Cumberland Pharmaceuticals is a specialty pharmaceutical company. Its stake in the sector includes its headquarters and commercial infrastructure. The company acquires and commercializes niche drugs, which requires a smaller R&D base than traditional pharmaceutical companies.
Market segment balance sheet capitalization - Pharma other
Cumberland Pharmaceuticals is a specialty pharmaceutical company. Its model is moderately capital-intensive. It has a commercial infrastructure for its niche hospital drugs. Compared to the pharmaceutical sector, it is heavier than R&D companies but lighter than the giants.
Book value of all companies included in the broad market index - GURU.Markets
Cumberland's assets are not research, but a portfolio of niche hospital drugs that the company acquires and commercializes. Its balance sheet reflects the value of the rights to these drugs. The chart shows the capital behind this business model, which is reviving important but forgotten drugs.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Cumberland Pharmaceuticals
Cumberland Pharmaceuticals is a specialty pharmaceutical company. Its market valuation reflects the value of its portfolio of existing niche drugs and its ability to acquire and develop new products.
Market to book capitalization ratio in a market segment - Pharma other
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires and develops niche drugs. Its business model is portfolio management. This chart shows how the market values its existing products and its ability to identify new growth opportunities.
Market to book capitalization ratio for the market as a whole
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires and develops niche drugs. Its business model combines scientific development and commercial expertise. The chart shows how the market evaluates this balanced model in the pharmaceutical industry compared to the overall market.
Debts of the company, segment and market as a whole
CPIX - Company debts Cumberland Pharmaceuticals
Cumberland Pharmaceuticals sells niche branded drugs. The company's strategy includes acquiring rights to undervalued drugs. Debt financing is a key tool for completing such transactions and expanding its pharmaceutical portfolio.
Market segment debts - Pharma other
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires and commercializes niche drugs. Its strategy is less risky than developing them from scratch. This chart shows how the company uses debt financing to acquire new products and how it manages its balance sheet to maximize cash flow from its portfolio.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Cumberland Pharmaceuticals
Cumberland Pharmaceuticals sells niche pharmaceuticals. This chart shows its debt load. Even with products on the market, the company can use debt to acquire new drugs or for marketing purposes. The risk is that the emergence of generics or new competitors could reduce sales and make debt servicing more difficult.
Market segment debt to market segment book capitalization - Pharma other
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires, develops, and commercializes niche prescription drugs. This chart compares its debt to the overall market capitalization of the pharmaceutical sector. It helps assess how the company is funding its strategy to fill gaps in the pharmaceutical market.
Debt to book value of all companies in the market
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires and develops niche drugs. This strategy may require debt to finance transactions. The chart shows how the company uses debt capital and how its debt load compares to other players in the pharmaceutical industry.
P/E of the company, segment and market as a whole
P/E - Cumberland Pharmaceuticals
This chart for Cumberland Pharmaceuticals, a specialty pharmaceutical company, evaluates its portfolio of niche drugs. The price-to-earnings ratio shows how investors view its ability to identify and commercialize products for smaller markets. The performance reflects the success of its marketing efforts and product life cycle.
P/E of the market segment - Pharma other
This chart shows the average valuation for the pharmaceutical industry—a benchmark for Cumberland. Comparing this company's valuation, operating in the hospital drug niche, to the broader sector average helps us understand how investors value its focused business model and ability to avoid competition from giants.
P/E of the market as a whole
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires, develops, and markets niche prescription drugs. Its strategy is to avoid direct competition with the giants. This chart reflects the state of the pharmaceutical industry. It helps us understand the success of the company's business model for discovering and commercializing undervalued drugs and how its diversified portfolio protects against risks.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Cumberland Pharmaceuticals
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires and develops niche hospital drugs. Its future profitability depends on the successful marketing of its products and the expansion of its portfolio. This chart shows how analysts assess the sales prospects of its existing drugs and the potential for new acquisitions.
%20P%2FE%20Cumberland%20Pharmaceuticals&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Cumberland-Pharmaceuticals&v=1772628137983 "Chart of the company's future (projected) P/E Cumberland Pharmaceuticals")
Future (projected) P/E of the market segment - Pharma other
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires, develops, and markets prescription drugs for hospital and outpatient use. This chart compares its future profitability expectations with those of the pharmaceutical industry, demonstrating how the market views its strategy for filling niche therapeutic needs.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-other&v=1772628137986 "Future (projected) P/E graph of the market segment - Pharma other")
Future (projected) P/E of the market as a whole
Cumberland Pharmaceuticals is a pharmaceutical company specializing in niche drugs for hospital use. This chart shows the overall sentiment in the healthcare sector. CPIX's business is relatively stable, as hospital demand for its drugs is not affected by economic cycles.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772628137988 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Cumberland Pharmaceuticals
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires, develops, and commercializes prescription drugs. This chart shows financial results based on sales of a portfolio of niche products, primarily for hospital use. Profits depend on the successful marketing of these drugs.
Profit of companies in the market segment - Pharma other
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires, develops, and markets prescription drugs for hospital and emergency use. This chart depicts the overall financial picture of the pharmaceutical industry, demonstrating how niche companies find their niche market share while avoiding competition from the giants.
Overall market profit
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires and commercializes niche drugs. Their business model is less risky than that of R&D companies. Demand for their drugs is generally stable. However, their success depends on their ability to identify and profitably acquire new assets.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Cumberland Pharmaceuticals
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires and commercializes niche hospital drugs. Its business model is based on identifying undervalued assets. This chart reflects analyst expectations for its drug portfolio.
%20profit%20of%20the%20company%20Cumberland%20Pharmaceuticals&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Cumberland-Pharmaceuticals&v=1772628138006 "Graph of future (projected) profit of the company Cumberland Pharmaceuticals")
Future (predicted) profit of companies in the market segment - Pharma other
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires, develops, and commercializes prescription drugs for the hospital and outpatient markets. This chart shows forecasts for the pharmaceutical sector. Cumberland's strategy avoids early-stage development risks, and its profitability depends on the successful marketing of its products.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-other&v=1772628138007 "Graph of future (predicted) profits of companies in a market segment - Pharma other")
Future (predicted) profit of the market as a whole
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires and commercializes niche drugs. Its success depends on its ability to identify promising products and the stability of the healthcare system. This graph, showing the profit forecast, is an indicator of overall economic health, which affects the solvency of hospitals and distributors.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772628138020 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Cumberland Pharmaceuticals
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires, develops, and markets niche prescription drugs. This chart shows how the market views its product portfolio. It reflects the stability of its drug sales and its success in bringing new drugs to market.
P/S market segment - Pharma other
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires, develops, and markets prescription drugs for the hospital and outpatient markets. This chart reflects the average pharmaceutical industry valuation, providing insight into how the market views Cumberland's diversified product portfolio and commercial strategy.
P/S of the market as a whole
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires and commercializes niche hospital drugs. Its business model is based on identifying undervalued assets. This chart helps assess how the market views the company's revenue generation strategy in narrow segments of the pharmaceutical market.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Cumberland Pharmaceuticals
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires, develops, and commercializes drugs for hospital and emergency use. This chart shows how investors estimate future revenue from sales of its drug portfolio. It depends on demand for its niche products.
%20P%2FS%20Cumberland%20Pharmaceuticals&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Cumberland-Pharmaceuticals&v=1772628138054 "The graph of the company's future (projected) P/S Cumberland Pharmaceuticals")
Future (projected) P/S of the market segment - Pharma other
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires and markets niche prescription drugs. This chart compares the company's estimated future sales with its industry. It reflects the market's assessment of its product portfolio and its ability to successfully commercialize them.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20other&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-other&v=1772628138070 "Future (projected) P/S market segment graph - Pharma other")
Future (projected) P/S of the market as a whole
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires, develops, and commercializes prescription drugs. This chart shows general expectations, while Cumberland focuses on niche products, often for hospital use. Its business model demonstrates how to identify growth opportunities in a mature pharmaceutical market.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772628138074 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Cumberland Pharmaceuticals
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires, develops, and markets niche prescription drugs. The revenue shown in this chart is generated from sales of its portfolio of products used primarily in hospital settings, such as injectable pain relievers.
Sales of companies in the market segment - Pharma other
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires, develops, and commercializes niche hospital drugs. Their strategy allows them to avoid competing with giants. This chart shows how even small companies can find a profitable niche in the vast pharmaceutical market.
Overall market sales
Cumberland Pharmaceuticals Inc. specializes in the acquisition and commercialization of niche pharmaceuticals. Its success depends on sales of existing products and successful acquisitions. The growth in total revenue, reflected in this chart, improves the financial health of hospitals, which are Cumberland's primary customers, ensuring stable demand.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Cumberland Pharmaceuticals
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires, develops, and markets niche prescription drugs, often for hospital use. This chart shows analyst expectations for sales of its drug portfolio and potential new acquisitions.
%20sales%20of%20the%20company%20Cumberland%20Pharmaceuticals&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Cumberland-Pharmaceuticals&v=1772628138098 "Schedule of future (projected) sales of the company Cumberland Pharmaceuticals")
Future (projected) sales of companies in the market segment - Pharma other
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires, develops, and commercializes prescription drugs. This chart shows forecasts for the pharmaceutical sector. It reflects a business model based on discovering and commercializing niche products within a larger industry.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-other&v=1772628138107 "Schedule of future (projected) sales of companies in the market segment - Pharma other")
Future (projected) sales of the market as a whole
Cumberland Pharmaceuticals, a specialty pharmaceutical company, sees this chart as an indicator of the stability of the healthcare system. The robust economy reflected here ensures predictability for hospitals and clinics, which are the primary customers for their hospital-based medications.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772628138108 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Cumberland Pharmaceuticals
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires and commercializes niche drugs. Unlike R&D companies, its profitability is directly dependent on sales of approved drugs. This chart shows how successfully the company manages its product portfolio to generate net profit.
Market segment marginality - Pharma other
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires, develops, and commercializes niche prescription drugs. Their effectiveness depends on their ability to identify undervalued assets and successfully commercialize them. The chart shows how profitable this business model is compared to R&D-focused companies.
Market marginality as a whole
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires and develops niche prescription drugs. Despite its overall profitability, Cumberland avoids competing with giants, focusing on smaller markets. Their profitability depends on successfully managing their drug portfolio.
Employees in the company, segment and market as a whole
Number of employees in the company Cumberland Pharmaceuticals
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires and commercializes niche drugs. This chart shows its team, including its commercial department. The size of its staff reflects its ability to market and sell its portfolio of approved drugs.
Share of the company's employees Cumberland Pharmaceuticals within the market segment - Pharma other
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires and develops niche hospital drugs. This chart shows the percentage of pharmaceutical professionals Cumberland attracts. It reflects its business model, which focuses on critical care and emergency care products.
Number of employees in the market segment - Pharma other
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires, develops, and markets prescription drugs. Its staff includes a commercial team and development specialists. This chart shows its operational activities. The staff dynamics reflect the life cycle of its products and its portfolio expansion efforts.
Number of employees in the market as a whole
Cumberland Pharmaceuticals is a specialty pharmaceutical company. Its success depends on its ability to discover and commercialize niche drugs. This chart shows the macro level, but for Cumberland, successful sales of its products and expanding its portfolio with new drugs are more important, which drives its HR policy.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Cumberland Pharmaceuticals (CPIX)
Cumberland Pharmaceuticals is a pharmaceutical company. This metric reflects both the value of its drugs (intellectual property) and the availability of a sales team. The graph shows the balance between the value of R&D and commercial efficiency.
%20of%20the%20company%20Cumberland%20Pharmaceuticals%20(CPIX)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Cumberland-Pharmaceuticals-CPIX&v=1772628138179 "Chart of market capitalization per employee (in thousands of dollars) of the company Cumberland Pharmaceuticals (CPIX)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma other
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires, develops, and commercializes approved or late-stage drugs. Its value lies in its ability to identify and successfully bring such products to market. This metric reflects the efficiency of its business model per employee.
%20by%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-other&v=1772628138182 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma other")
Market capitalization per employee (in thousands of dollars) for the overall market
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires, develops, and markets niche prescription drugs. Its business model is commercialization. This chart shows how the market evaluates the team's ability to discover and successfully commercialize drugs for small, underserved patient populations.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772628138199 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Cumberland Pharmaceuticals (CPIX)
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires and commercializes niche drugs (often for hospitals). This chart shows how effectively their small sales and marketing team can revitalize and sell these undervalued drugs.
%20Chart%20Cumberland%20Pharmaceuticals%20(CPIX)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Cumberland-Pharmaceuticals-CPIX&v=1772628138219 "Company Profit Per Employee (in thousands of dollars) Chart Cumberland Pharmaceuticals (CPIX)")
Profit per employee (in thousands of dollars) in the market segment - Pharma other
Cumberland Pharmaceuticals (CPIX) is a specialty pharmaceutical company that acquires, develops, and commercializes niche hospital drugs. This chart demonstrates the effectiveness of their commercial model. It reflects how successfully their sales team promotes their portfolio of drugs to hospitals, generating revenue per employee.
%20in%20the%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-other&v=1772628138239 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma other")
Profit per employee (in thousands of dollars) for the market as a whole
Cumberland Pharmaceuticals is a specialty pharmaceutical company. It already has a portfolio of approved drugs that it sells to hospitals. This is the commercial stage. This chart shows how effectively the company sells its niche products. Revenue per employee here depends on the drug's margins and the effectiveness of its small sales team.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772628138250 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Cumberland Pharmaceuticals (CPIX)
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires, develops, and markets prescription drugs. This chart demonstrates the effectiveness of their commercial strategy. It shows how much revenue each employee generates from sales of their approved drug portfolio.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Cumberland-Pharmaceuticals-CPIX&v=1772628138269 "Sales chart per company employee Cumberland Pharmaceuticals (CPIX)")
Sales per employee in the market segment - Pharma other
Cumberland Pharmaceuticals is a niche pharmaceutical company that acquires, develops, and markets medications for emergency care and gastrointestinal care. This chart shows the average revenue per employee in the sector. It helps assess how effective Cumberland's commercial team is in promoting its niche drug portfolio in hospitals.
Sales per employee for the market as a whole
Cumberland Pharmaceuticals (CPIX) is a specialty pharmaceutical company. They acquire, develop, and market niche hospital medications (e.g., acetaminophen injection). This chart shows how effectively their small sales team sells this portfolio of niche products to hospitals.
Short shares by company, segment and market as a whole
Shares shorted by company Cumberland Pharmaceuticals (CPIX)
Cumberland Pharmaceuticals is a niche pharmaceutical company that acquires and sells little-known hospital drugs. This model has limited growth. The chart shows the number of investors who bet the company will face generic competition or that its portfolio of older drugs will fail to generate growth.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Cumberland-Pharmaceuticals-CPIX&v=1772628138298 "Short Shares Chart for the Company Cumberland Pharmaceuticals (CPIX)")
Shares shorted by market segment - Pharma other
Cumberland Pharmaceuticals is a niche (specialty) pharmaceutical company that sells approved drugs for the hospital segment. This chart shows bearish sentiment in the sector. It rises when investors anticipate increased competition (for example, from generics) or price pressure from hospitals.
Shares shorted by the overall market
Cumberland Pharmaceuticals sells niche hospital drugs. Unlike biotechs, they have revenue, but they struggle to grow. This chart illustrates the overall pessimism. When investors are fearful, they look for either explosive growth or rock-solid stability. CPIX, somewhere in the middle, meets neither requirement. Investors fear generic competition and are selling the stock.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Cumberland Pharmaceuticals (CPIX)
Cumberland Pharmaceuticals is a pharmaceutical company specializing in hospital drugs. Rather than embark on risky developments, they often launch already approved or niche products. This chart shows how the market reacts to their sales reports, indicating "overbought" (above 70) during growth or "oversold" (below 30) during increased competition.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Cumberland-Pharmaceuticals-CPIX&v=1772628138321 "RSI 14 indicator chart for the company's stock Cumberland Pharmaceuticals (CPIX)")
RSI 14 Market Segment - Pharma other
Cumberland (CPIX) is a "specialty" pharma. They don't *do* R&D, but *commercialize* (sell) *niche* brand-name drugs (for *hospitals* and *gastroenterology*). The "Pharma other" sector lives on "cycles." RSI\_14\_Seg shows the "temperature" of the *entire* industry. It helps us understand: is CPIX's growth a "niche" or a general "hype"?
RSI 14 for the overall market
Cumberland Pharma (CPIX) supplies hospital medications. This chart shows that its business is "defensive." Demand for its products isn't affected by euphoria or panic—they're emergency medicine. During times of market panic, investors seek safe havens in companies with non-cyclical demand.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast CPIX (Cumberland Pharmaceuticals)
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires and sells niche branded hospital medications (e.g., Acetadote, Caldolor). This chart shows the average 12-month forecast from analysts. It reflects their view on the life cycle of their drug portfolio and their ability to secure new deals.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-CPIX-Cumberland-Pharmaceuticals&v=1772628138372 "A chart showing analyst consensus forecasts for the expected stock price. CPIX (Cumberland Pharmaceuticals)")
The difference between the consensus estimate and the actual stock price CPIX (Cumberland Pharmaceuticals)
Cumberland Pharma is a niche pharmaceutical company. Its strategy is to acquire and commercialize approved but neglected drugs for the hospital market. This chart shows how the current share price differs from the "fair" value predicted by analysts. It reflects their belief in this business model.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-CPIX-Cumberland-Pharmaceuticals&v=1772628138380 "A chart showing the difference between the consensus forecast and the actual stock price. CPIX (Cumberland Pharmaceuticals)")
Analyst consensus forecast for stock prices by market segment - Pharma other
Cumberland is a niche pharmaceutical company. It doesn't invent blockbusters, but rather acquires and sells hospital-grade drugs (primarily injectables) that are needed immediately. This chart shows analysts' overall expectations for the entire pharmaceutical sector. It reflects whether experts believe the hospital-grade segment is stable.
Analysts' consensus forecast for the overall market share price
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires and commercializes niche, often hospital-grade, drugs. This chart shows overall market sentiment. For Cumberland, which operates in the defensive healthcare sector, overall optimism is important, but their business is valued for its stability, as they sell approved drugs.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Cumberland Pharmaceuticals
Cumberland Pharmaceuticals is a boutique pharma company. They don't engage in R&D from scratch, but rather specialize in rescuing and commercializing niche, often hospital-grade, drugs that were approved but abandoned by big pharma. This chart is a summary indicator of their portfolio. It reflects their ability to manage sales of these niche products and their M&A strategy to find new orphans.
AKIMA Market Segment Index - Pharma other
Cumberland Pharmaceuticals (CPIX) is a specialty pharmaceutical company that acquires, develops, and markets niche prescription drugs (e.g., for emergency care and gastroenterology). The chart shows the average index for the segment. It helps investors assess how successful Cumberland's business model for commercializing niche drugs is compared to the average.
The AKIM Index for the overall market
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires and commercializes branded drugs for hospitals. This chart, which reflects the market average, provides a macro backdrop. It helps assess how CPIX, a niche player with a diverse product portfolio, compares to overall healthcare economic trends.
